Lv52
900 积分 2023-05-16 加入
Discovery of a Potent and Orally Bioavailable Xanthine Oxidase/Urate Transporter 1 Dual Inhibitor as a Potential Treatment for Hyperuricemia and Gout
3天前
已完结
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma
16天前
已完结
Role of IL‐5 in asthma and airway remodelling
16天前
已完结
Efficacy and Safety of Tezepelumab in Adults With Severe, Uncontrolled Asthma in Asia: Results From the Phase 3 DIRECTION Study
17天前
已完结
Tezepelumab: An Anti-Thymic Stromal Lymphopoietin Monoclonal Antibody for the Treatment of Asthma
17天前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
23天前
已完结
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
23天前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
23天前
已完结
Prevalence of Chronic Obstructive Pulmonary Disease in Adults Aged 40 Years and Older in China From 2014 to 2024: A Systematic Review and Meta-Analysis
24天前
已完结
Burden of chronic respiratory disease in Asia, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
24天前
已完结
皖公网安备34019202002308
